After the 1996 Dickey Amendment halted federal spending on research into firearms risks, a small group of academics pressed on, with little money or political support, to document the nation’s growing gun violence problem and start to understand what can be done to curb the public health crisis.
Measles activity is rising nationwide, with nearly half of states reporting new cases in 2024, CDC data shows.
Another updated version of the COVID-19 vaccine is expected to be available this fall, around the same time flu shots are rolled out, CDC Director Mandy Cohen, MD, told Bloomberg in an interview March 4.
A recently unsealed lawsuit alleges Aledade Inc. developed billing software that boosted revenues by making patients appear sicker than they were.
A mathematical model designed to direct spending of opioid settlement funds is at the center of a debate over whether to invest in technology to guide long-term decisions or focus on the immediate needs of people in addiction.
A new California law allows trained physician assistants, also called physician associates, to perform first-trimester abortions without the presence of a supervising doctor. The legislation is part of a broader effort by the state to expand access to abortion care, especially in rural areas. Some doctor groups are wary.
Once eliminated from the U.S., measles appears to be making a comeback, with 41 cases reported so far in 2024. That amount is already more than half of the total number of cases reported in 2023, according to CDC data.
As respiratory virus season’s effect on the nation’s healthcare system wanes, 26 states are still seeing high levels of activity, according to the CDC’s latest update, which reflects data through the week of Feb. 24.
The U.S. is seeing fewer hospitalizations and deaths from COVID-19 with the addition of more tools to manage it, like vaccines and medication. In updated respiratory virus guidance published March 1, the CDC stated “it is no longer the emergency that i…
There are now more than 1 billion people are now classified as ‘obese’ worldwide, according to a March 1 update from the World Health Organization. But the rise of anti-obesity medications like Ozempic and Mounjaro should not be considered a solution, …
